These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Melatonin ameliorates disease severity in a mouse model of multiple sclerosis by modulating the kynurenine pathway. Jand Y; Ghahremani MH; Ghanbari A; Ejtemaei-Mehr S; Guillemin GJ; Ghazi-Khansari M Sci Rep; 2022 Sep; 12(1):15963. PubMed ID: 36153399 [TBL] [Abstract][Full Text] [Related]
63. Thinking outside the box: non-canonical targets in multiple sclerosis. Bierhansl L; Hartung HP; Aktas O; Ruck T; Roden M; Meuth SG Nat Rev Drug Discov; 2022 Aug; 21(8):578-600. PubMed ID: 35668103 [TBL] [Abstract][Full Text] [Related]
64. Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases. González LF; Bevilacqua LE; Naves R Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959337 [TBL] [Abstract][Full Text] [Related]
65. Therapeutic Potentials of Poly (ADP-Ribose) Polymerase 1 (PARP1) Inhibition in Multiple Sclerosis and Animal Models: Concept Revisiting. Wang Y; Pleasure D; Deng W; Guo F Adv Sci (Weinh); 2022 Feb; 9(5):e2102853. PubMed ID: 34935305 [TBL] [Abstract][Full Text] [Related]
66. Cross-Sectional Associations between Dietary Daily Nicotinamide Intake and Patient-Reported Outcomes in Colorectal Cancer Survivors, 2 to 10 Years Post-Diagnosis. Wu W; Bours MJL; Koole A; Kenkhuis MF; Eussen SJPM; Breukink SO; van Schooten FJ; Weijenberg MP; Hageman GJ Nutrients; 2021 Oct; 13(11):. PubMed ID: 34835963 [TBL] [Abstract][Full Text] [Related]
67. Exploring the roles of tryptophan metabolism in MS beyond neuroinflammation and neurodegeneration: A paradigm shift to neuropsychiatric symptoms. Tan LSY; Francis HM; Lim CK Brain Behav Immun Health; 2021 Mar; 12():100201. PubMed ID: 34589733 [TBL] [Abstract][Full Text] [Related]
68. NADomics: Measuring NAD Braidy N; Villalva MD; Grant R Life (Basel); 2021 May; 11(6):. PubMed ID: 34073099 [TBL] [Abstract][Full Text] [Related]
69. In Vivo Molecular Changes in the Retina of Patients With Multiple Sclerosis. Alba-Arbalat S; Andorra M; Sanchez-Dalmau B; Camos-Carreras A; Dotti-Boada M; Pulido-Valdeolivas I; Llufriu S; Blanco Y; Sepulveda M; Saiz A; Batet O; Bilbao I; Torre I; Amat-Roldan I; Martinez-Lapiscina EH; Villoslada P Invest Ophthalmol Vis Sci; 2021 May; 62(6):11. PubMed ID: 33974046 [TBL] [Abstract][Full Text] [Related]
70. Nicotinamide adenine dinucleotide metabolism in the immune response, autoimmunity and inflammageing. Navarro MN; Gómez de Las Heras MM; Mittelbrunn M Br J Pharmacol; 2022 May; 179(9):1839-1856. PubMed ID: 33817782 [TBL] [Abstract][Full Text] [Related]
71. Sex-related differences in human plasma NAD+/NADH levels depend on age. Schwarzmann L; Pliquett RU; Simm A; Bartling B Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33393613 [TBL] [Abstract][Full Text] [Related]
72. Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives. Biernacki T; Sandi D; Bencsik K; Vécsei L Cells; 2020 Jun; 9(6):. PubMed ID: 32604956 [TBL] [Abstract][Full Text] [Related]
79. Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis. Malhotra S; Fissolo N; Tintoré M; Wing AC; Castilló J; Vidal-Jordana A; Montalban X; Comabella M J Neuroinflammation; 2015 Mar; 12():48. PubMed ID: 25879961 [TBL] [Abstract][Full Text] [Related]
80. IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Caggiula M; Mirabella M; Tonali PA; Batocchi AP Cytokine; 2008 Oct; 44(1):22-5. PubMed ID: 18793860 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]